Neovascularization in tissue engineering

Cells

Volumn 1, Issue 4, 2012, Pages 1246-1260

  Chung, Jennifer C Y ^a   Shum Tim, Dominique ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Angiogenesis; Endothelial progenitor cells; Neovascularization; Therapeutic angiogenesis

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; FIBROBLAST GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1; MOLECULAR SCAFFOLD; PLATELET DERIVED GROWTH FACTOR; PROTEIN BCL 2; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; BONE MARROW CELL; CELL BASED GENE THERAPY; CELL THERAPY; CONTROLLED CLINICAL TRIAL (TOPIC); ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HUMAN; HYPOXIA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TISSUE ENGINEERING; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84898541012     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells1041246     Document Type: Review

References (88)

1. Griffith, C.K.; Miller, C.; Sainson, R.C.; Calvert, J.W.; Jeon, N.L.; Hughes, C.C.; George, S.C. Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng. 2005, 11, 257-266.
2. Patan, S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J. Neurooncol. 2000, 50, 1-15.
3. Jain, R.K.; Schlenger, K.; Hockel, M.; Yuan, F. Quantitative angiogenesis assays: Progress and problems. Nat. Med. 1997, 3, 1203-1208.
4. Roy, R.; Zhang, B.; Moses, M.A. Making the cut: protease-mediated regulation of angiogenesis. Exp. Cell. Res. 2006, 312, 608-622.
5. Simon-Yarza, T.; Formiga, F.R.; Tamayo, E.; Pelacho, B.; Prosper, F.; Blanco-Prieto, M.J. Vascular endothelial growth factor-delivery systems for cardiac repair: An overview. Theranostics 2012, 2, 541-552.
6. Eppler, S.M.; Combs, D.L.; Henry, T.D.; Lopez, J.J.; Ellis, S.G.; Yi, J.H.; Annex, B.H.; McCluskey, E.R.; Zioncheck, T.F. A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans. Exp. Cell. Res. 2002, 72, 20-32.
7. Hendel, R.C.; Henry, T.D.; Rocha-Singh, K.; Isner, J.M.; Kereiakes, D.J.; Giordano, F.J.; Simons, M.; Bonow, R.O. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation 2000, 101, 118-121.
8. Henry, T.D.; Annex, B.H.; McKendall, G.R.; Azrin, M.A.; Lopez, J.J.; Giordano, F.J.; Shah, P.K.; Willerson, J.T.; Benza, R.L.; Berman, D.S.; et al. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 2003, 107, 1359-1365.
9. Cleland, J.L.; Duenas, E.T.; Park, A.; Daugherty, A.; Kahn, J.; Kowalski, J.; Cuthbertson, A. Development of poly-(D, L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J. Control Release 2001, 72, 13-24.
10. Wu, J.; Zeng, F.; Huang, X.P.; Chung, J.C.; Konecny, F.; Weisel, R.D.; Li, R.K. Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel. Biomaterials 2011, 32, 579-586.
11. Otrock, Z.K.; Mahfouz, R.A.; Makarem, J.A.; Shamseddine, A.I. Understanding the biology of angiogenesis: Review of the most important molecular mechanisms. Blood Cells Mol. Dis. 2007, 39, 212-220.
12. Bertolino, P.; Deckers, M.; Lebrin, F.; ten Dijke, P. Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest 2005, 128, S585-S590.
13. Cross, M.J.; Claesson-Welsh, L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 2001, 22, 201-207.
14. Isner, J.M.; Pieczek, A.; Schainfeld, R.; Blair, R.; Haley, L.; Asahara, T.; Rosenfield, K.; Razvi, S.; Walsh, K.; Symes, J.F. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 1996, 348, 370-374.
15. Kastrup, J.; Jorgensen, E.; Ruck, A.; Tagil, K.; Glogar, D.; Ruzyllo, W.; Botker, H.E.; Dudek, D.; Drvota, V.; Hesse, B.; et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J. Am. Coll. Cardiol. 2005, 45, 982-988.
16. Rosengart, T.K.; Lee, L.Y.; Patel, S.R.; Sanborn, T.A.; Parikh, M.; Bergman, G.W.; Hachamovitch, R.; Szulc, M.; Kligfield, P.D.; Okin, P.M.; et al. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999, 100, 468-474.
17. Hedman, M.; Hartikainen, J.; Yla-Herttuala, S. Progress and prospects: hurdles to cardiovascular gene therapy clinical trials. Gene Ther. 2011, 18, 743-749.
18. Ozawa, C.R.; Banfi, A.; Glazer, N.L.; Thurston, G.; Springer, M.L.; Kraft, P.E.; McDonald, D.M.; Blau, H.M. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J. Clin. Invest. 2004, 113, 516-527.
19. Vredenburgh, J.J.; Desjardins, A.; Herndon, J.E., 2nd; Marcello, J.; Reardon, D.A.; Quinn, J.A.; Rich, J.N.; Sathornsumetee, S.; Gururangan, S.; Sampson, J.; et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J. Clin. Oncol. 2007, 25, 4722-4729.
20. Wagner, A.D.; Arnold, D.; Grothey, A.A.; Haerting, J.; Unverzagt, S. Anti-angiogenic therapies for metastatic colorectal cancer. Cochrane Database Syst. Rev. 2009, CD005392.
21. Pang, R.; Poon, R.T. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett. 2006, 242, 151-167.
22. Richardson, T.P.; Peters, M.C.; Ennett, A.B.; Mooney, D.J. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 2001, 19, 1029-1034.
23. Hao, X.; Silva, E.A.; Mansson-Broberg, A.; Grinnemo, K.H.; Siddiqui, A.J.; Dellgren, G.; Wardell, E.; Brodin, L.A.; Mooney, D.J.; Sylven, C. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc. Res. 2007, 75, 178-185.
24. Freeman, I.; Cohen, S. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials 2009, 30, 2122-2131.
25. Feraud, O.; Cao, Y.; Vittet, D. Embryonic stem cell-derived embryoid bodies development in collagen gels recapitulates sprouting angiogenesis. Lab. Invest. 2001, 81, 1669-1681.
26. Lafleur, M.A.; Handsley, M.M.; Knauper, V.; Murphy, G.; Edwards, D.R. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J. Cell Sci. 2002, 115, 3427-3438.
27. Chekanov, V.; Akhtar, M.; Tchekanov, G.; Dangas, G.; Shehzad, M.Z.; Tio, F.; Adamian, M.; Colombo, A.; Roubin, G.; Leon, M.B.; et al. Transplantation of autologous endothelial cells induces angiogenesis. Pacing Clin. Electrophysiol. 2003, 26, 496-499.
28. Schechner, J.S.; Nath, A.K.; Zheng, L.; Kluger, M.S.; Hughes, C.C.; Sierra-Honigmann, M.R.; Lorber, M.I.; Tellides, G.; Kashgarian, M.; Bothwell, A.L.; et al. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc. Natl. Acad. Sci. USA 2000, 97, 9191-9196.
29. Kocher, A.A.; Schuster, M.D.; Szabolcs, M.J.; Takuma, S.; Burkhoff, D.; Wang, J.; Homma, S.; Edwards, N.M.; Itescu, S. Neovascularization of ischemic myocardium by human bone-marrowderived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001, 7, 430-436.
30. Hur, J.; Yoon, C.H.; Kim, H.S.; Choi, J.H.; Kang, H.J.; Hwang, K.K.; Oh, B.H.; Lee, M.M.; Park, Y.B. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 288-293.
31. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G.; Isner, J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275, 964-967.
32. Asahara, T.; Masuda, H.; Takahashi, T.; Kalka, C.; Pastore, C.; Silver, M.; Kearne, M.; Magner, M.; Isner, J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999, 85, 221-228.
33. Melero-Martin, J.M.; Khan, Z.A.; Picard, A.; Wu, X.; Paruchuri, S.; Bischoff, J. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 2007, 109, 4761-4768.
34. Melero-Martin, J.M.; De Obaldia, M.E.; Kang, S.Y.; Khan, Z.A.; Yuan, L.; Oettgen, P.; Bischoff, J. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ. Res. 2008, 103, 194-202.
35. Au, P.; Daheron, L.M.; Duda, D.G.; Cohen, K.S.; Tyrrell, J.A.; Lanning, R.M.; Fukumura, D.; Scadden, D.T.; Jain, R.K. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 2008, 111, 1302-1305.
36. Murohara, T. Autologous adipose tissue as a new source of progenitor cells for therapeutic angiogenesis. J. Cardiol. 2009, 53, 155-163.
37. Lin, Y.; Weisdorf, D.J.; Solovey, A.; Hebbel, R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 2000, 105, 71-77.
38. Yoon, C.H.; Hur, J.; Park, K.W.; Kim, J.H.; Lee, C.S.; Oh, I.Y.; Kim, T.Y.; Cho, H.J.; Kang, H.J.; Chae, I.H.; et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005, 112, 1618-1627.
39. Fadini, G.P.; Losordo, D.; Dimmeler, S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ. Res. 2012, 110, 624-637.
40. Darland, D.C.; D'Amore, P.A. Blood vessel maturation: Vascular development comes of age. J. Clin. Invest. 1999, 103, 157-158.
41. Jain, R.K. Molecular regulation of vessel maturation. Nat. Med. 2003, 9, 685-693.
42. Ceradini, D.J.; Kulkarni, A.R.; Callaghan, M.J.; Tepper, O.M.; Bastidas, N.; Kleinman, M.E.; Capla, J.M.; Galiano, R.D.; Levine, J.P.; Gurtner, G.C. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 2004, 10, 858-864.
43. Schioppa, T.; Uranchimeg, B.; Saccani, A.; Biswas, S.K.; Doni, A.; Rapisarda, A.; Bernasconi, S.; Saccani, S.; Nebuloni, M.; Vago, L.; et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 2003, 198, 1391-1402.
44. Dragu, A.; Schnurer, S.; Surmann-Schmitt, C.; Unglaub, F.; Kneser, U.; Horch, R.E. Expression of HIF-1alpha in ischemia and reperfusion in human microsurgical free muscle tissue transfer. Plast. Reconstr. Surg. 2011, 127, 2293-2300.
45. Foresta, C.; Schipilliti, M.; De Toni, L.; Magagna, S.; Lancerotto, L.; Azzena, B.; Vindigni, V.; Mazzoleni, F. Blood levels, apoptosis, and homing of the endothelial progenitor cells after skin burns and escharectomy. J. Trauma 2011, 70, 459-465.
46. Bosch-Marce, M.; Okuyama, H.; Wesley, J.B.; Sarkar, K.; Kimura, H.; Liu, Y.V.; Zhang, H.; Strazza, M.; Rey, S.; Savino, L.; et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ. Res. 2007, 101, 1310-1318.
47. Semenza, G.L. HIF-1 and human disease: One highly involved factor. Genes Dev. 2000, 14, 1983-1991.
48. Uemura, R.; Xu, M.; Ahmad, N.; Ashraf, M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 2006, 98, 1414-1421.
49. Ma, T.; Grayson, W.L.; Frohlich, M.; Vunjak-Novakovic, G. Hypoxia and stem cell-based engineering of mesenchymal tissues. Biotechnol. Prog. 2009, 25, 32-42.
50. Volkmer, E.; Drosse, I.; Otto, S.; Stangelmayer, A.; Stengele, M.; Kallukalam, B.C.; Mutschler, W.; Schieker, M. Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue Eng. Part A 2008, 14, 1331-1340.
51. Hedman, M.; Hartikainen, J.; Syvanne, M.; Stjernvall, J.; Hedman, A.; Kivela, A.; Vanninen, E.; Mussalo, H.; Kauppila, E.; Simula, S.; et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003, 107, 2677-2683.
52. White, J.D.; Thesier, D.M.; Swain, J.B.; Katz, M.G.; Tomasulo, C.; Henderson, A.; Wang, L.; Yarnall, C.; Fargnoli, A.; Sumaroka, M.; et al. Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo. Gene Ther. 2011, 18, 546-552.
53. Bridges, C.R.; Gopal, K.; Holt, D.E.; Yarnall, C.; Cole, S.; Anderson, R.B.; Yin, X.; Nelson, A.; Kozyak, B.W.; Wang, Z.; et al. Efficient myocyte gene delivery with complete cardiac surgical isolation in situ. J. Thorac. Cardiovasc. Surg. 2005, 130, 1364.
54. Laschke, M.W.; Rucker, M.; Jensen, G.; Carvalho, C.; Mulhaupt, R.; Gellrich, N.C.; Menger, M.D. Improvement of vascularization of PLGA scaffolds by inosculation of in situ-preformed functional blood vessels with the host microvasculature. Ann. Surg. 2008, 248, 939-948.
55. Lu, W.N.; Lu, S.H.; Wang, H.B.; Li, D.X.; Duan, C.M.; Liu, Z.Q.; Hao, T.; He, W.J.; Xu, B.; Fu, Q.; et al. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng. Part A 2009, 15, 1437-1447.
56. Lee, J.; Bae, Y.H.; Sohn, Y.S.; Jeong, B. Thermogelling aqueous solutions of alternating multiblock copolymers of poly(L-lactic acid) and poly(ethylene glycol). Biomacromolecules 2006, 7, 1729-1734.
57. Narmoneva, D.A.; Oni, O.; Sieminski, A.L.; Zhang, S.; Gertler, J.P.; Kamm, R.D.; Lee, R.T. Self-assembling short oligopeptides and the promotion of angiogenesis. Biomaterials 2005, 26, 4837-4846.
58. Shapira-Schweitzer, K.; Habib, M.; Gepstein, L.; Seliktar, D. A photopolymerizable hydrogel for 3-D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells. J. Mol. Cell. Cardiol. 2009, 46, 213-224.
59. Rouwkema, J.; Rivron, N.C.; van Blitterswijk, C.A. Vascularization in tissue engineering. Trends Biotechnol. 2008, 26, 434-441.
60. Druecke, D.; Langer, S.; Lamme, E.; Pieper, J.; Ugarkovic, M.; Steinau, H.U.; Homann, H.H. Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: long-term investigations using intravital fluorescent microscopy. J. Biomed. Mater. Res. A 2004, 68, 10-18.
61. Davis, M.E.; Hsieh, P.C.; Grodzinsky, A.J.; Lee, R.T. Custom design of the cardiac microenvironment with biomaterials. Circ. Res. 2005, 97, 8-15.
62. Chan, B.P.; Leong, K.W. Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur. Spine J. 2008, 17 (Suppl. 4), 467-479.
63. Shi, X.; Su, K.; Varshney, R.R.; Wang, Y.; Wang, D.A. Sintered microsphere scaffolds for controlled release and tissue engineering. Pharm. Res. 2011, 28, 1224-1228.
64. Jabbarzadeh, E.; Starnes, T.; Khan, Y.M.; Jiang, T.; Wirtel, A.J.; Deng, M.; Lv, Q.; Nair, L.S.; Doty, S.B.; Laurencin, C.T. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach. Proceedings of the Proc. Natl. Acad. Sci. USA 2008, 105, 11099-11104.
65. Yu, J.; Du, K.T.; Fang, Q.; Gu, Y.; Mihardja, S.S.; Sievers, R.E.; Wu, J.C.; Lee, R.J. The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials 2010, 31, 7012-7020.
66. Sun, Q.; Silva, E.A.; Wang, A.; Fritton, J.C.; Mooney, D.J.; Schaffler, M.B.; Grossman, P.M.; Rajagopalan, S. Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis. Pharm. Res. 2010, 27, 264-271.
67. Lee, J.; Lee, K.Y. Local and sustained vascular endothelial growth factor delivery for angiogenesis using an injectable system. Pharm. Res. 2009, 26, 1739-1744.
68. Layman, H.; Li, X.; Nagar, E.; Vial, X.; Pham, S.M.; Andreopoulos, F.M. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres. J. Biomater. Sci. Polym. Ed. 2012, 23, 185-206.
69. Paul, A.; Shao, W.; Shum-Tim, D.; Prakash, S. The attenuation of restenosis following arterial gene transfer using carbon nanotube coated stent incorporating TAT/DNA(Ang1+Vegf) nanoparticles. Biomaterials 2012, 33, 7655-7664.
70. Zawicki, D.F.; Jain, R.K.; Schmid-Schoenbein, G.W.; Chien, S. Dynamics of neovascularization in normal tissue. Microvasc. Res. 1981, 21, 27-47.
71. Greenblatt, M.; Shubi, P. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. J. Natl. Cancer Inst. 1968, 41, 111-124.
72. Auerbach, R.; Lewis, R.; Shinners, B.; Kubai, L.; Akhtar, N. Angiogenesis assays: A critical overview. Clin. Chem. 2003, 49, 32-40.
73. Muthukkaruppan, V.; Auerbach, R. Angiogenesis in the mouse cornea. Science 1979, 205, 1416-1418.
74. Erol, O.O.; Spira, M. New capillary bed formation with a surgically constructed arteriovenous fistula. Surg. Forum 1979, 30, 530-531.
75. Lokmic, Z.; Stillaert, F.; Morrison, W.A.; Thompson, E.W.; Mitchell, G.M. An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. FASEB J. 2007, 21, 511-522.
76. Arkudas, A.; Tjiawi, J.; Bleiziffer, O.; Grabinger, L.; Polykandriotis, E.; Beier, J.P.; Sturzl, M.; Horch, R.E.; Kneser, U. Fibrin gel-immobilized VEGF and bFGF efficiently stimulate angiogenesis in the AV loop model. Mol. Med. 2007, 13, 480-487.
77. Staton, C.A.; Reed, M.W.; Brown, N.J. A critical analysis of current in vitro and in vivo angiogenesis assays. Int. J. Exp. Pathol. 2009, 90, 195-221.
78. Miyagi, Y.; Chiu, L.L.; Cimini, M.; Weisel, R.D.; Radisic, M.; Li, R.K. Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. Biomaterials 2011, 32, 1280-1290.
79. Schumacher, B.; Pecher, P.; von Specht, B.U.; Stegmann, T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998, 97, 645-650.
80. Pecher, P.; Schumacher, B.A. Angiogenesis in ischemic human myocardium: Clinical results after 3 years. Ann. Thorac. Surg. 2000, 69, 1414-1419.
81. Azrin, M. Angiogenesis, protein and gene delivery. Br. Med. Bull. 2001, 59, 211-225.
82. Zachary, I.; Morgan, R.D. Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects. Heart 2011, 97, 181-189.
83. Simons, M.; Annex, B.H.; Laham, R.J.; Kleiman, N.; Henry, T.; Dauerman, H.; Udelson, J.E.; Gervino, E.V.; Pike, M.; Whitehouse, M.J.; et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 2002, 105, 788-793.
84. Henry, T.D.; Grines, C.L.; Watkins, M.W.; Dib, N.; Barbeau, G.; Moreadith, R.; Andrasfay, T.; Engler, R.L. Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials. J. Am. Coll. Cardiol. 2007, 50, 1038-1046.
85. Rajagopalan, S.; Mohler, E.R., 3rd; Lederman, R.J.; Mendelsohn, F.O.; Saucedo, J.F.; Goldman, C.K.; Blebea, J.; Macko, J.; Kessler, P.D.; Rasmussen, H.S.; et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003, 108, 1933-1938.
86. Dincer, S.; Turk, M.; Piskin, E. Intelligent polymers as nonviral vectors. Gene Ther. 2005, 12 Suppl 1, S139-145.
87. Isner, J.M. Myocardial gene therapy. Nature 2002, 415, 234-239.
88. Wollert, K.C.; Meyer, G.P.; Lotz, J.; Ringes-Lichtenberg, S.; Lippolt, P.; Breidenbach, C.; Fichtner, S.; Korte, T.; Hornig, B.; Messinger, D.; et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364, 141-148.